Sign in Pull a receipt

NAUT

Nautilus Biotechnology, Inc.

Healthcare · Biotechnology

$299.92 sample

+4.41 (+1.49%) 1D

Market cap

$1.80T

Price as of

2026-10-29

Latest filing

8-K · 2026-09-24

Alerts

8

Price$299.92 +19.34% 3M daily closessample

309.11249.38

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Chief Financial Officer
Oct 20INSInsider sell: Director
Oct 09INSInsider buy: Chief Executive Officer
Oct 02INSInsider buy: EVP, Operations
Sep 24SEC8-K filed: material event
Sep 16INSInsider buy: EVP, Operations
Sep 07INSInsider sell: Chief Financial Officer
Aug 27SECDEF 14A filed

Sign up to see the real NAUT record →

Company facts

SEC EDGAR registration

Name: Nautilus Biotechnology, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +35sample, -100 to +100
Reporting currency: USD

Who is positioning in NAUT

sample

Insiders: 26 insider transactions over 90 days, net selling, $46.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 26 funds hold $36.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$50.7B +16.2% y/y

Q4 2024Q3 2026

Inventory$30.5B +7.4% y/y

Q4 2024Q3 2026

Accounts receivable$23.8B +19.3% y/y

Q4 2024Q3 2026

Total debt$64.7B +21.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.76T +13.2% 3M
Sample peer B: $1.60T +12.7% 3M
Sample peer C: $1.06T -7.7% 3M
Sample peer D: $287.5B -8.3% 3M
Sample peer E: $419.1B +16.2% 3M